Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Bluetongue Virus in France: An Illustration of the European and Mediterranean Context since the 2000s.

Kundlacz C, Caignard G, Sailleau C, Viarouge C, Postic L, Vitour D, Zientara S, Breard E.

Viruses. 2019 Jul 23;11(7). pii: E672. doi: 10.3390/v11070672. Review.

2.

Novel Function of Bluetongue Virus NS3 Protein in Regulation of the MAPK/ERK Signaling Pathway.

Kundlacz C, Pourcelot M, Fablet A, Amaral Da Silva Moraes R, Léger T, Morlet B, Viarouge C, Sailleau C, Turpaud M, Gorlier A, Breard E, Lecollinet S, van Rijn PA, Zientara S, Vitour D, Caignard G.

J Virol. 2019 Jul 30;93(16). pii: e00336-19. doi: 10.1128/JVI.00336-19. Print 2019 Aug 15.

PMID:
31167915
3.

Evaluation of an IGM-specific ELISA for early detection of bluetongue virus infections in domestic ruminants sera.

Bréard E, Gorlier A, Viarouge C, Donnet F, Sailleau C, Schulz C, Hoffmann B, Comtet L, Beer M, Zientara S, Vitour D.

Transbound Emerg Dis. 2019 Jan;66(1):537-545. doi: 10.1111/tbed.13060. Epub 2018 Nov 23.

PMID:
30394662
4.

Emergence of bluetongue virus serotype 4 in mainland France in November 2017.

Sailleau C, Breard E, Viarouge C, Gorlier A, Leroux A, Hirchaud E, Lucas P, Blanchard Y, Vitour D, Grandcollot-Chabot M, Zientara S.

Transbound Emerg Dis. 2018 Oct;65(5):1158-1162. doi: 10.1111/tbed.12919. Epub 2018 Jun 8.

PMID:
29885075
5.

Bluetongue virus serotype 27: Experimental infection of goats, sheep and cattle with three BTV-27 variants reveal atypical characteristics and likely direct contact transmission BTV-27 between goats.

Bréard E, Schulz C, Sailleau C, Bernelin-Cottet C, Viarouge C, Vitour D, Guillaume B, Caignard G, Gorlier A, Attoui H, Gallois M, Hoffmann B, Zientara S, Beer M.

Transbound Emerg Dis. 2018 Apr;65(2):e251-e263. doi: 10.1111/tbed.12780. Epub 2017 Dec 15.

PMID:
29243405
6.

Fetopathic effects of experimental Schmallenberg virus infection in pregnant goats.

Laloy E, Bréard E, Trapp S, Pozzi N, Riou M, Barc C, Breton S, Delaunay R, Cordonnier N, Chateau-Joubert S, Crochet D, Gouzil J, Hébert T, Raimbourg M, Viarouge C, Vitour D, Durand B, Ponsart C, Zientara S.

Vet Microbiol. 2017 Nov;211:141-149. doi: 10.1016/j.vetmic.2017.10.011. Epub 2017 Oct 14.

PMID:
29102110
7.

Bluetongue Virus: From BTV-1 to BTV-27.

Belbis G, Zientara S, Bréard E, Sailleau C, Caignard G, Vitour D, Attoui H.

Adv Virus Res. 2017;99:161-197. doi: 10.1016/bs.aivir.2017.08.003. Epub 2017 Sep 22.

PMID:
29029725
8.

Serological status for BTV-8 in French cattle prior to the 2015 re-emergence.

Courtejoie N, Durand B, Bréard E, Sailleau C, Vitour D, Zientara S, Gorlier A, Baurier F, Gourmelen C, Benoit F, Achour H, Milard C, Poliak S, Pagneux C, Viarouge C, Zanella G.

Transbound Emerg Dis. 2018 Feb;65(1):e173-e182. doi: 10.1111/tbed.12718. Epub 2017 Sep 22.

PMID:
28940827
9.

Ring trial 2016 for Bluetongue virus detection by real-time RT-PCR in France.

Sailleau C, Viarouge C, Breard E, Vitour D, Zientara S.

Vet Med Sci. 2017 Apr 16;3(2):107-114. doi: 10.1002/vms3.63. eCollection 2017 May.

10.

Complete genome sequence of bluetongue virus serotype 4 that emerged on the French island of Corsica in December 2016.

Sailleau C, Breard E, Viarouge C, Gorlier A, Quenault H, Hirchaud E, Touzain F, Blanchard Y, Vitour D, Zientara S.

Transbound Emerg Dis. 2018 Feb;65(1):e194-e197. doi: 10.1111/tbed.12660. Epub 2017 May 11.

PMID:
28497659
11.

Circulation of bluetongue virus 8 in French cattle, before and after the re-emergence in 2015.

Courtejoie N, Durand B, Bournez L, Gorlier A, Bréard E, Sailleau C, Vitour D, Zientara S, Baurier F, Gourmelen C, Benoit F, Achour H, Milard C, Poliak S, Pagneux C, Viarouge C, Zanella G.

Transbound Emerg Dis. 2018 Feb;65(1):281-284. doi: 10.1111/tbed.12652. Epub 2017 May 2.

PMID:
28464486
12.

Nonstructural Protein NSs of Schmallenberg Virus Is Targeted to the Nucleolus and Induces Nucleolar Disorganization.

Gouzil J, Fablet A, Lara E, Caignard G, Cochet M, Kundlacz C, Palmarini M, Varela M, Breard E, Sailleau C, Viarouge C, Coulpier M, Zientara S, Vitour D.

J Virol. 2016 Dec 16;91(1). pii: e01263-16. doi: 10.1128/JVI.01263-16. Print 2017 Jan 1.

13.

Development of a Double-Antigen Microsphere Immunoassay for Simultaneous Group and Serotype Detection of Bluetongue Virus Antibodies.

Breard E, Garnier A, Despres P, Blaise Boisseau S, Comtet L, Viarouge C, Bakkali-Kassimi L, Pourquier P, Hudelet P, Vitour D, Rossi S, Belbis G, Sailleau C, Zientara S.

Transbound Emerg Dis. 2017 Dec;64(6):1837-1847. doi: 10.1111/tbed.12578. Epub 2016 Sep 25.

PMID:
27667484
14.

The Golgi apparatus acts as a platform for TBK1 activation after viral RNA sensing.

Pourcelot M, Zemirli N, Silva Da Costa L, Loyant R, Garcin D, Vitour D, Munitic I, Vazquez A, Arnoult D.

BMC Biol. 2016 Aug 18;14:69. doi: 10.1186/s12915-016-0292-z.

15.

Bluetongue virus serotype 27: detection and characterization of two novel variants in Corsica, France.

Schulz C, Bréard E, Sailleau C, Jenckel M, Viarouge C, Vitour D, Palmarini M, Gallois M, Höper D, Hoffmann B, Beer M, Zientara S.

J Gen Virol. 2016 Sep;97(9):2073-2083. doi: 10.1099/jgv.0.000557. Epub 2016 Jul 19.

PMID:
27435041
16.

Complete Genome Sequence of Bluetongue Virus Serotype 8, Which Reemerged in France in August 2015.

Bréard E, Sailleau C, Quenault H, Lucas P, Viarouge C, Touzain F, Fablet A, Vitour D, Attoui H, Zientara S, Blanchard Y.

Genome Announc. 2016 Apr 14;4(2). pii: e00163-16. doi: 10.1128/genomeA.00163-16.

17.

Re-Emergence of Bluetongue Virus Serotype 8 in France, 2015.

Sailleau C, Bréard E, Viarouge C, Vitour D, Romey A, Garnier A, Fablet A, Lowenski S, Gorna K, Caignard G, Pagneux C, Zientara S.

Transbound Emerg Dis. 2017 Jun;64(3):998-1000. doi: 10.1111/tbed.12453. Epub 2015 Nov 30.

PMID:
26617414
18.

Turnover Rate of NS3 Proteins Modulates Bluetongue Virus Replication Kinetics in a Host-Specific Manner.

Ftaich N, Ciancia C, Viarouge C, Barry G, Ratinier M, van Rijn PA, Breard E, Vitour D, Zientara S, Palmarini M, Terzian C, Arnaud F.

J Virol. 2015 Oct;89(20):10467-81. doi: 10.1128/JVI.01541-15. Epub 2015 Aug 5.

19.

Duplex Real-Time RT-PCR Assays for the Detection and Typing of Epizootic Haemorrhagic Disease Virus.

Viarouge C, Breard E, Zientara S, Vitour D, Sailleau C.

PLoS One. 2015 Jul 10;10(7):e0132540. doi: 10.1371/journal.pone.0132540. eCollection 2015.

20.

Benefits of PCR and decentralization of diagnosis in regional laboratories in the management of Bluetongue in France.

Zientara S, Sailleau C, Bréard E, Viarouge C, Doceul V, Vitour D.

Vet Ital. 2015 Oct-Dec;51(4):393-9. doi: 10.12834/VetIt.512.3148.2.

PMID:
26129786
21.

Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.

Breard E, Belbis G, Viarouge C, Nomikou K, Haegeman A, De Clercq K, Hudelet P, Hamers C, Moreau F, Lilin T, Durand B, Mertens P, Vitour D, Sailleau C, Zientara S.

Vaccine. 2015 Jan 15;33(4):512-8. doi: 10.1016/j.vaccine.2014.11.053. Epub 2014 Dec 11.

PMID:
25500308
22.

Novel bluetongue virus in goats, Corsica, France, 2014.

Zientara S, Sailleau C, Viarouge C, Höper D, Beer M, Jenckel M, Hoffmann B, Romey A, Bakkali-Kassimi L, Fablet A, Vitour D, Bréard E.

Emerg Infect Dis. 2014 Dec;20(12):2123-5. doi: 10.3201/eid2012.140924.

23.

Identification of bluetongue virus and epizootic hemorrhagic disease virus serotypes in French Guiana in 2011 and 2012.

Viarouge C, Lancelot R, Rives G, Bréard E, Miller M, Baudrimont X, Doceul V, Vitour D, Zientara S, Sailleau C.

Vet Microbiol. 2014 Nov 7;174(1-2):78-85. doi: 10.1016/j.vetmic.2014.09.006. Epub 2014 Sep 22.

PMID:
25301282
24.

Dual modulation of type I interferon response by bluetongue virus.

Doceul V, Chauveau E, Lara E, Bréard E, Sailleau C, Zientara S, Vitour D.

J Virol. 2014 Sep;88(18):10792-802. doi: 10.1128/JVI.01235-14. Epub 2014 Jul 9.

25.

Immunisation with bacterial expressed VP2 and VP5 of bluetongue virus (BTV) protect α/β interferon-receptor knock-out (IFNAR(-/-)) mice from homologous lethal challenge.

Mohd Jaafar F, Belhouchet M, Vitour D, Adam M, Breard E, Zientara S, Mertens PP, Attoui H.

Vaccine. 2014 Jul 7;32(32):4059-67. doi: 10.1016/j.vaccine.2014.05.056. Epub 2014 Jun 2.

26.

Evidence of excretion of Schmallenberg virus in bull semen.

Ponsart C, Pozzi N, Bréard E, Catinot V, Viard G, Sailleau C, Viarouge C, Gouzil J, Beer M, Zientara S, Vitour D.

Vet Res. 2014 Apr 4;45:37. doi: 10.1186/1297-9716-45-37.

27.

Emergence of Bluetongue Virus Serotype 1 in French Corsica Island in September 2013.

Sailleau C, Viarouge C, Bréard E, Perrin JB, Doceul V, Vitour D, Zientara S.

Transbound Emerg Dis. 2015 Oct;62(5):e89-91. doi: 10.1111/tbed.12207. Epub 2014 Jan 24.

PMID:
24456375
28.

Induction and control of the type I interferon pathway by Bluetongue virus.

Vitour D, Doceul V, Ruscanu S, Chauveau E, Schwartz-Cornil I, Zientara S.

Virus Res. 2014 Mar;182:59-70. doi: 10.1016/j.virusres.2013.10.027. Epub 2013 Nov 7. Review.

PMID:
24211608
29.

Schmallenberg virus infection in dogs, France, 2012.

Sailleau C, Boogaerts C, Meyrueix A, Laloy E, Bréard E, Viarouge C, Desprat A, Vitour D, Doceul V, Boucher C, Zientara S, Nicolier A, Grandjean D.

Emerg Infect Dis. 2013 Nov;19(11):1896-8. doi: 10.3201/eid1911.130464. No abstract available.

30.

Epizootic hemorrhagic disease virus serotype 6 experimentation on adult cattle.

Breard E, Belbis G, Viarouge C, Riou M, Desprat A, Moreau J, Laloy E, Martin G, Sarradin P, Vitour D, Batten C, Doceul V, Sailleau C, Zientara S.

Res Vet Sci. 2013 Oct;95(2):794-8. doi: 10.1016/j.rvsc.2013.06.026. Epub 2013 Jul 27.

PMID:
23899717
31.

Dendritic cell subtypes from lymph nodes and blood show contrasted gene expression programs upon Bluetongue virus infection.

Ruscanu S, Jouneau L, Urien C, Bourge M, Lecardonnel J, Moroldo M, Loup B, Dalod M, Elhmouzi-Younes J, Bevilacqua C, Hope J, Vitour D, Zientara S, Meyer G, Schwartz-Cornil I.

J Virol. 2013 Aug;87(16):9333-43. doi: 10.1128/JVI.00631-13. Epub 2013 Jun 19.

32.

Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe.

Doceul V, Lara E, Sailleau C, Belbis G, Richardson J, Bréard E, Viarouge C, Dominguez M, Hendrikx P, Calavas D, Desprat A, Languille J, Comtet L, Pourquier P, Eléouët JF, Delmas B, Marianneau P, Vitour D, Zientara S.

Vet Res. 2013 May 15;44:31. doi: 10.1186/1297-9716-44-31. Review.

33.

NS3 of bluetongue virus interferes with the induction of type I interferon.

Chauveau E, Doceul V, Lara E, Breard E, Sailleau C, Vidalain PO, Meurs EF, Dabo S, Schwartz-Cornil I, Zientara S, Vitour D.

J Virol. 2013 Jul;87(14):8241-6. doi: 10.1128/JVI.00678-13. Epub 2013 May 8.

34.

[Vaccination against two vector-borne diseases: bluetongue and West Nile].

Zientara S, Vitour D, Lecollinet S.

Bull Acad Natl Med. 2012 Mar;196(3):591-601; discussion 601-2, 619-20. French.

PMID:
23472349
35.

Acute Schmallenberg virus infections, France, 2012.

Sailleau C, Bréard E, Viarouge C, Desprat A, Doceul V, Lara E, Languille J, Vitour D, Attoui H, Zientara S.

Emerg Infect Dis. 2013 Feb;19(2):321-2. No abstract available.

36.

Validation of a commercially available indirect ELISA using a nucleocapside recombinant protein for detection of Schmallenberg virus antibodies.

Bréard E, Lara E, Comtet L, Viarouge C, Doceul V, Desprat A, Vitour D, Pozzi N, Cay AB, De Regge N, Pourquier P, Schirrmeier H, Hoffmann B, Beer M, Sailleau C, Zientara S.

PLoS One. 2013;8(1):e53446. doi: 10.1371/journal.pone.0053446. Epub 2013 Jan 15.

37.

Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases.

Chauveau E, Doceul V, Lara E, Adam M, Breard E, Sailleau C, Viarouge C, Desprat A, Meyer G, Schwartz-Cornil I, Ruscanu S, Charley B, Zientara S, Vitour D.

J Virol. 2012 Nov;86(21):11789-99. doi: 10.1128/JVI.00430-12. Epub 2012 Aug 22.

38.

Difficulties in the interpretation of bluetongue RT-PCR results in France.

Zientara S, Amat JP, Sailleau C, Viarouge C, Desprat A, Vitour D, Bréard E.

Vet Rec. 2012 Jun 9;170(23):599. doi: 10.1136/vr.100485. Epub 2012 May 1. No abstract available.

PMID:
22550123
39.

The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathway.

Ruscanu S, Pascale F, Bourge M, Hemati B, Elhmouzi-Younes J, Urien C, Bonneau M, Takamatsu H, Hope J, Mertens P, Meyer G, Stewart M, Roy P, Meurs EF, Dabo S, Zientara S, Breard E, Sailleau C, Chauveau E, Vitour D, Charley B, Schwartz-Cornil I.

J Virol. 2012 May;86(10):5817-28. doi: 10.1128/JVI.06716-11. Epub 2012 Mar 21.

40.

Co-circulation of bluetongue and epizootic haemorrhagic disease viruses in cattle in Reunion Island.

Sailleau C, Zanella G, Breard E, Viarouge C, Desprat A, Vitour D, Adam M, Lasne L, Martrenchar A, Bakkali-Kassimi L, Costes L, Zientara S.

Vet Microbiol. 2012 Mar 23;155(2-4):191-7. doi: 10.1016/j.vetmic.2011.09.006. Epub 2011 Sep 21.

PMID:
22005178
41.

Colostral antibody induced interference of inactivated bluetongue serotype-8 vaccines in calves.

Vitour D, Guillotin J, Sailleau C, Viarouge C, Desprat A, Wolff F, Belbis G, Durand B, Bakkali-Kassimi L, Breard E, Zientara S, Zanella G.

Vet Res. 2011 Feb 2;42:18. doi: 10.1186/1297-9716-42-18.

42.

A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients.

Pothlichet J, Niewold TB, Vitour D, Solhonne B, Crow MK, Si-Tahar M.

EMBO Mol Med. 2011 Mar;3(3):142-52. doi: 10.1002/emmm.201000120. Epub 2011 Jan 26.

43.

Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS.

Vitour D, Dabo S, Ahmadi Pour M, Vilasco M, Vidalain PO, Jacob Y, Mezel-Lemoine M, Paz S, Arguello M, Lin R, Tangy F, Hiscott J, Meurs EF.

J Biol Chem. 2009 Aug 14;284(33):21797-809. doi: 10.1074/jbc.M109.018275. Epub 2009 Jun 22.

44.

Nuclear localization of cytoplasmic poly(A)-binding protein upon rotavirus infection involves the interaction of NSP3 with eIF4G and RoXaN.

Harb M, Becker MM, Vitour D, Baron CH, Vende P, Brown SC, Bolte S, Arold ST, Poncet D.

J Virol. 2008 Nov;82(22):11283-93. doi: 10.1128/JVI.00872-08. Epub 2008 Sep 17.

45.

Regulation of interferon production by RIG-I and LGP2: a lesson in self-control.

Vitour D, Meurs EF.

Sci STKE. 2007 May 1;2007(384):pe20.

PMID:
17473309
46.

Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells.

Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, Si-Tahar M.

J Immunol. 2007 Mar 15;178(6):3368-72.

47.

The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers.

Vilasco M, Larrea E, Vitour D, Dabo S, Breiman A, Regnault B, Riezu JI, Eid P, Prieto J, Meurs EF.

Hepatology. 2006 Dec;44(6):1635-47.

PMID:
17133498
48.

A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells.

Breiman A, Vitour D, Vilasco M, Ottone C, Molina S, Pichard L, Fournier C, Delgrange D, Charneau P, Duverlie G, Wychowski C, Maurel P, Meurs EF.

J Gen Virol. 2006 Dec;87(Pt 12):3587-98.

PMID:
17098974
49.

Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage.

Lin R, Lacoste J, Nakhaei P, Sun Q, Yang L, Paz S, Wilkinson P, Julkunen I, Vitour D, Meurs E, Hiscott J.

J Virol. 2006 Jun;80(12):6072-83.

Supplemental Content

Loading ...
Support Center